Molecular Biology of the Cell click for CBE Life Science Education Page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E04-08-0672 on November 24, 2004

Vol. 16, Issue 2, 757-768, February 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
E04-08-0672v1
16/2/757    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sottile, J.
Right arrow Articles by Chandler, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sottile, J.
Right arrow Articles by Chandler, J.

Fibronectin Matrix Turnover Occurs through a Caveolin-1–dependent Process

Jane Sottile *, and Jennifer Chandler

Center for Cardiovascular Research, Department of Medicine, University of Rochester, Rochester, NY 14642

Submitted August 6, 2004; Accepted November 10, 2004
Monitoring Editor: Jean Schwarzbauer

Extracellular matrix remodeling occurs during development, tissue repair, and in a number of pathologies, including fibrotic disorders, hypertension, and atherosclerosis. Extracellular matrix remodeling involves the complex interplay between extracellular matrix synthesis, deposition, and degradation. Factors that control these processes are likely to play key roles in regulating physiological and pathological extracellular matrix remodeling. Our data show that fibronectin polymerization into the extracellular matrix regulates the deposition and stability of other extracellular matrix proteins, including collagen I and thrombospondin-1 (Sottile and Hocking, 2002. Mol. Biol. Cell 13, 3546). In the absence of continual fibronectin polymerization, there is a loss of fibronectin matrix fibrils, and increased levels of fibronectin degradation. Fibronectin degradation occurs intracellularly after endocytosis and can be inhibited by chloroquine, an inhibitor of lysosomal degradation, and by caveolae-disrupting agents. Down-regulation of caveolin-1 by RNAi inhibits loss of fibronectin matrix fibrils, fibronectin internalization, and fibronectin degradation; these processes can be restored by reexpression of caveolin-1. These data show that fibronectin matrix turnover occurs through a caveolin-1–dependent process. Caveolin-1 regulation of fibronectin matrix turnover is a novel mechanism regulating extracellular matrix remodeling.


Article published online ahead of print in MBC in Press on November 24, 2004 (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E04-08-0672).

Abbreviations used: BSA, bovine serum albumin; ECM, extracellular matrix; GST, glutathione S-transferase; LPA, lysophophatidic acid; LRP, low-density lipoprotein receptor–related protein; MFI, mean fluorescence intensity; MMP, matrix metalloproteinase; short hairpin RNA (shRNA); SMC, smooth muscle cell; RAP, receptor-associated protein.

* Corresponding author. E-mail address: jane_sottile{at}urmc.rochester.edu.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
E. Monaghan-Benson, C. C. Mastick, and P. J. McKeown-Longo
A dual role for caveolin-1 in the regulation of fibronectin matrix assembly by uPAR
J. Cell Sci., November 15, 2008; 121(22): 3693 - 3703.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. Shi and J. Sottile
Caveolin-1-dependent {beta}1 integrin endocytosis is a critical regulator of fibronectin turnover
J. Cell Sci., July 15, 2008; 121(14): 2360 - 2371.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Peng, B. Zhang, D. Wu, A. J. Ingram, B. Gao, and J. C. Krepinsky
TGF{beta}-induced RhoA activation and fibronectin production in mesangial cells require caveolae
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F153 - F164.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
J. G. Goetz, B. Joshi, P. Lajoie, S. S. Strugnell, T. Scudamore, L. D. Kojic, and I. R. Nabi
Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1
J. Cell Biol., March 24, 2008; 180(6): 1261 - 1275.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Beer and L. Pedersen
Matrix Fibronectin Binds Gammaretrovirus and Assists in Entry: New Light on Viral Infections
J. Virol., August 1, 2007; 81(15): 8247 - 8257.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. H.J. Heerkens, A. S. Izzard, and A. M. Heagerty
Integrins, Vascular Remodeling, and Hypertension
Hypertension, January 1, 2007; 49(1): 1 - 4.
[Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Schroder, B. Schroder, B. Roppenser, S. Linder, B. Sinha, R. Fassler, and M. Aepfelbacher
Staphylococcus aureus Fibronectin Binding Protein-A Induces Motile Attachment Sites and Complex Actin Remodeling in Living Endothelial Cells
Mol. Biol. Cell, December 1, 2006; 17(12): 5198 - 5210.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Ray, E. C. Osmundson, and H. Kiyokawa
Constitutive and UV-induced Fibronectin Degradation Is a Ubiquitination-dependent Process Controlled by beta-TrCP
J. Biol. Chem., August 11, 2006; 281(32): 23060 - 23065.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Monaghan-Benson and P. J. McKeown-Longo
Urokinase-type Plasminogen Activator Receptor Regulates a Novel Pathway of Fibronectin Matrix Assembly Requiring Src-dependent Transactivation of Epidermal Growth Factor Receptor
J. Biol. Chem., April 7, 2006; 281(14): 9450 - 9459.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. B. Carson-Walter, J. Hampton, E. Shue, D. M. Geynisman, P. K. Pillai, R. Sathanoori, S. L. Madden, R. L. Hamilton, and K. A. Walter
Plasmalemmal Vesicle Associated Protein-1 Is a Novel Marker Implicated in Brain Tumor Angiogenesis
Clin. Cancer Res., November 1, 2005; 11(21): 7643 - 7650.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Tkachenko, J. M. Rhodes, and M. Simons
Syndecans: New Kids on the Signaling Block
Circ. Res., March 18, 2005; 96(5): 488 - 500.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2005 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.